I

Inkef

22 employees

Inkef focuses on early-stage venture investing in European companies active in technology and healthcare.

Investor insights

Countries invested in

united states1

Sectors invested in

Biotechnology23
Medical16
Software15
Health Care15
Pharmaceutical13
Therapeutics12
Medical Device8
Artificial Intelligence7
Technology7
SaaS6
Financial Services6
Information Technology6
FinTech6
Machine Learning5
Biopharma5
Life Science5
Marketplace5
Medical Devices and Diabetes4
Electronics4
Hardware4

Funding rounds participated in

$12M sweet spot round size

Most of their 69 investments are in rounds between $6.3M and $31M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
therapeutics
LifeScience
Finance
DigitalHealth
DeepTech
Techstartups
Healthcare
Software
VCfunding
Enterprise SaaS
Venture Capital

Date founded

2010

Investments made

A

Anavo Therapeutics BV raised $9.3M on May 2, 2023

Investors: M Ventures, Bioqube Ventures and Inkef

Q

QurAlis raised $88M on March 9, 2023

Investors: Sanofi Ventures, Life Sciences Partners (LSP), MP Healthcare Venture Management Inc, Mission Bay Capital, EQT Life Sciences, Mission BioCapital and Inkef

Q

Quantum Motion Technologies raised $51M on February 21, 2023

Investors: Oxford Sciences Innovation, Robert Bosch Venture Capital GmbH (RBVC), IP Group plc, Parkwalk Advisors, Octopus Ventures, Porsche Automobil Holding SE, British Patient Capital and Inkef

H

Happeo raised $26M on July 7, 2022

Investors: Smartfin, Maki.vc, Evli Growth Partners, Vendep Capital and Inkef

B

Baserow raised $5.1M on July 6, 2022

Investors: firstminute capital, Frontline, Seedcamp and Inkef

P

Precirix raised $88M on March 16, 2022

Investors: Gimv, Pontifax Venture Capital, HealthCap, Novo Holdings, V-Bio Ventures, BioMedPartners, Forbion and Inkef

C

ChannelEngine raised $50M on March 15, 2022

Investors: General Catalyst, Atomico, Airbridge Equity Partners and Inkef

S

Scenic Biotech raised $31M on March 10, 2022

Investors: Oxford Sciences Innovation, Eir Ventures, BGV (BioGeneration Ventures), BioMedPartners and Inkef

T

TargED Biopharmaceuticals raised $44M on February 19, 2022

Investors: Utrecht Holdings (Universiteit Utrecht), Andera Partners, Sunstone Life Science Ventures, FundPlus, Hadean Ventures, Curie Capital BV and Inkef

N

NMD Pharma raised $40M on February 15, 2022

Investors: Novo Holdings, JEITO and Inkef

FAQ